PTC Therapeutics Inc PTCT

NAS: PTCT | ISIN: US69366J2006   15:30
38,26 USD (+15,59%)
(+15,59%)   15:30

20 mei 2024 · PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation · Persbericht

14 mei 2024 · PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ · Persbericht

2 mei 2024 · PTC Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

25 april 2024 · PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results · Persbericht

23 april 2024 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

11 april 2024 · PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results · Persbericht

28 maart 2024 · PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA · Persbericht

19 maart 2024 · PTC Therapeutics Provides Key Regulatory Updates · Persbericht

29 februari 2024 · PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results · Persbericht

27 februari 2024 · PTC Therapeutics to Participate at Upcoming Investor Conferences · Persbericht

22 februari 2024 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

15 februari 2024 · PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results · Persbericht

25 januari 2024 · CHMP Issues Negative Opinion for Renewal of Conditional Marketing Authorization for Translarna™ (ataluren) Following Re-examination Procedure · Persbericht

8 januari 2024 · PTC Therapeutics Provides an Update on Commercial Progress and R&D Pipeline at 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

3 januari 2024 · PTC Therapeutics to Participate at 42nd Annual J.P. Morgan Healthcare Conference · Persbericht

14 december 2023 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

5 december 2023 · PTC Therapeutics Provides Updates on Translarna™ Regulatory Activities · Persbericht

3 november 2023 · PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · Persbericht

27 oktober 2023 · Thinking about buying stock in Rivian Automotive, Heritage Global, Enphase Energy, PTC Therapeutics, or Hanryu Holdings? · Persbericht

26 oktober 2023 · PTC Therapeutics Provides Corporate Update and Reports Third Quarter Financial Results · Persbericht

Mijn selecties